Optimizing Medtech Pricing Flexibility in a Digital World: Subscription Versus CapEx
As medtech companies modify their business practices and pricing models to draw out the maximum value of their integrated digital and medical device offerings and respond to customers’ concerns about high up-front costs of adopting new technologies, they need to discern the trade-offs and proper use cases.
Optimizing Medtech Pricing Flexibility in a Digital World: Subscription Versus CapEx
Published in MedTech Strategist
Authors: Wendy Diller with Thomas F. Busby and
Oded Ben-Joseph
Abstract:
As medtech companies modify their business practices and pricing models to draw out the maximum value of their integrated digital and medical device offerings and respond to customers’ concerns about high up-front costs of adopting new technologies, they need to discern the trade-offs and proper use cases.
News
ProjectMedtech Podcast | Strategic Transactions in MedTech: Insights & Advice
Recent podcast conversation featuring Stanislav Glezer, Managing Director at Outcome Capital, on the ProjectMedtech Podcast, hosted by Duane Mancini.
Read MoreResources
Outcome Capital Life Science Market Pulse
Outcome Capital Life Science Market Pulse February 2026 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2026. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
